Related Experiment Video
Updated: May 22, 2026
06:38
In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells
Published on: March 7, 2025
Discoveries in Down syndrome: moving basic science to clinical care
A M Kleschevnikov1, P V Belichenko, A Salehi
1Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA. akleschevnikov@yahoo.com
Progress in Brain Research
|May 1, 2012
Summary
Recent discoveries in Down syndrome (DS) neurobiology, using mouse models, reveal potential pharmacological treatments for cognitive deficits. Strategies focus on synaptic plasticity and neuromodulatory systems in young animals and amyloid precursor protein processing in older ones.
Area of Science:
- Neurobiology
- Genetics
- Pharmacology
Background:
- Down syndrome (DS) is associated with cognitive disabilities.
- Mouse models are crucial for understanding DS neurobiology.
- Identifying therapeutic targets for cognitive function is a priority.
Purpose of the Study:
- To review recent neurobiological discoveries in Down syndrome using mouse models.
- To provide an overview of experimental approaches for pharmacological restoration of cognitive function in DS.
- To discuss molecular and cellular mechanisms underlying cognitive deficits in DS.
Main Methods:
- Utilizing mouse genetic models of Down syndrome.
- Analyzing synaptic structure and function in the hippocampal formation.
- Investigating alterations in hippocampal innervation by neuromodulatory systems.
- Examining mechanisms of amyloid precursor protein (App) misprocessing and related neurodegenerative processes.
Main Results:
- Changes in synaptic connections and neuromodulatory systems in DS mouse models offer therapeutic clues.
- Dysfunctional axonal transport and endosomal pathways are linked to "Alzheimer-type" neurodegeneration in DS.
- Therapeutic strategies targeting synaptic plasticity, neurogenesis, and neuromodulatory systems show promise in juvenile DS models.
- Strategies for older DS models focus on recuperating misprocessed App and related proteins.
Conclusions:
- Mouse models have identified potential therapeutic targets for cognitive deficits in Down syndrome.
- Pharmacological interventions targeting synaptic plasticity, neurogenesis, and App processing may restore cognitive function.
- Further research and clinical trials are needed to translate these findings into effective treatments for individuals with DS.
Related Concept Videos
01:17Karyotyping
Overview
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:49Meiosis I
Meiosis is a carefully orchestrated set of cell divisions, the goal of which—in humans—is to produce haploid sperm or eggs, each containing half the number of chromosomes present in somatic cells elsewhere in the body. Meiosis I is the first such division, and involves several key steps, among them: condensation of replicated chromosomes in diploid cells; the pairing of homologous chromosomes and their exchange of information; and finally, the separation of homologous chromosomes by a...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.